top of page
Pipeline
NanoGhost Therapeutic Pipeline
NanoGhost is developing a pipeline of encapsulated therapeutics for targeted delivery into multiple oncological indications
Oncology
Candidate
Target Indication
Development Phase
Discovery
Preclinical
Phase I
Phase II
Phase III
NG-2001
mRNA, IL-12
Immune Oncology, Solid Tumors, TBD
NG-4001
Foreign Antigen TBD
Immune Oncology, Solid Tumors, TBD
Solid Tumors, TBD
NG-3001
DNA/Oncolytic Virus
(Collaboration with GeneMedicine)
NG-1001
Small Molecule, SN-38
Solid Tumors, TBD
NG-1002
Small Molecule, Olaparib
Solid Tumors, TBD
bottom of page